Thus our data demonstrate a novel regulatory loop between miR26A1-EZH2 and TET1 and thus providing an explanation for consistent upregulation of TET1 and EZH2 in CLL patients while miR26A1 is hypermethylated. This evidence concerns the gene EZH2 and B-cell chronic lymphocytic leukemia.